SAN DIEGO, April 01, 2024 aTyr Pharma, Inc. , a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase.
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]